Auxilium, Endo, GSK Reach Potential Settlement Of Testosterone MDL Cases

(February 26, 2018, 1:24 PM EST) -- CHICAGO — Testosterone replacement therapy drug makers Auxilium Pharmaceuticals LLC, Endo Pharmaceuticals Inc. and GlaxoSmithKline LLC (GSK) have entered into a potential global settlement, according to a Feb. 23 order by...
To view the full article, register now.